| Date Filed | Type | Description |
| 08/18/2023 |
4
| Donovan Joanne M. (CMO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 05/03/2023 |
4
| Donovan Joanne M. (CMO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 3,254 shares
@ $8.9049, valued at
$29k
Exercised 10,416 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Donovan Joanne M. (CMO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $16.38, valued at
$2.6M
|
|
| 05/04/2021 |
4
| Donovan Joanne M. (CMO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $28.64, valued at
$4.6M
|
|
| 05/04/2021 |
3
| Donovan Joanne M. (CMO) has filed a Form 3 on Edgewise Therapeutics, Inc. |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2018 |
4
| Donovan Joanne M. (CMO; SVP Clinical Development) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $0.71, valued at
$106.5k
|
|
| 02/09/2018 |
4
| Donovan Joanne M. (CMO; SVP Clinical Development) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $1.28, valued at
$128k
|
|
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2016 |
4/A
| Donovan Joanne M. (CMO; SVP Clinical Development) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 09/12/2016 |
4
| Donovan Joanne M. (CMO; SVP Clinical Development) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $4.3, valued at
$193.5k
|
|